| Bioactivity | CD3254 a potent and selective retinoid-X-receptor (RXR) agonist[1]. | ||||||||||||
| Invitro | CD3254 induces similar phenotypes of malformations after 5 days exposure at low concentration (20 μg/L) to those after the 1st d exposure at high concentrations (50 and 100 μg/L)[1]. Cell Viability Assay[1] Cell Line: | ||||||||||||
| Name | CD3254 | ||||||||||||
| CAS | 196961-43-0 | ||||||||||||
| Formula | C24H28O3 | ||||||||||||
| Molar Mass | 364.48 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Nahoum V, et al. Modulators of the structural dynamics of the retinoid X receptor to reveal receptor function. Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17323-8. |